125 related articles for article (PubMed ID: 36052494)
1. RARγ: The Bone of Contention for Endothelial Cells in Prostate Cancer Metastasis.
Bhowmick S; Bhowmick NA
Cancer Res; 2022 Sep; 82(17):2975-2976. PubMed ID: 36052494
[TBL] [Abstract][Full Text] [Related]
2. Retinoic Acid Receptor Activation Reduces Metastatic Prostate Cancer Bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.
Yu G; Corn PG; Shen P; Song JH; Lee YC; Lin SC; Pan J; Agarwal SK; Panaretakis T; Pacifici M; Logothetis CJ; Yu-Lee LY; Lin SH
Cancer Res; 2022 Sep; 82(17):3158-3171. PubMed ID: 35802768
[TBL] [Abstract][Full Text] [Related]
3. The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.
Barruet E; Morales BM; Lwin W; White MP; Theodoris CV; Kim H; Urrutia A; Wong SA; Srivastava D; Hsiao EC
Stem Cell Res Ther; 2016 Aug; 7(1):115. PubMed ID: 27530160
[TBL] [Abstract][Full Text] [Related]
4. Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva.
Fukuda T; Kohda M; Kanomata K; Nojima J; Nakamura A; Kamizono J; Noguchi Y; Iwakiri K; Kondo T; Kurose J; Endo K; Awakura T; Fukushi J; Nakashima Y; Chiyonobu T; Kawara A; Nishida Y; Wada I; Akita M; Komori T; Nakayama K; Nanba A; Maruki Y; Yoda T; Tomoda H; Yu PB; Shore EM; Kaplan FS; Miyazono K; Matsuoka M; Ikebuchi K; Ohtake A; Oda H; Jimi E; Owan I; Okazaki Y; Katagiri T
J Biol Chem; 2009 Mar; 284(11):7149-56. PubMed ID: 18684712
[TBL] [Abstract][Full Text] [Related]
5. Cartilage-derived retinoic acid-sensitive protein (CD-RAP): A stage-specific biomarker of heterotopic endochondral ossification (HEO) in fibrodysplasia ossificans progressiva (FOP).
Lindborg CM; Brennan TA; Wang H; Kaplan FS; Pignolo RJ
Bone; 2018 Apr; 109():153-157. PubMed ID: 28963080
[TBL] [Abstract][Full Text] [Related]
6. Palovarotene: First Approval.
Hoy SM
Drugs; 2022 Apr; 82(6):711-716. PubMed ID: 35384641
[TBL] [Abstract][Full Text] [Related]
7. Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP).
Wang H; Shore EM; Pignolo RJ; Kaplan FS
Bone; 2018 Apr; 109():218-224. PubMed ID: 29170109
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem-cell contribution to ectopic skeletogenesis.
Kaplan FS; Glaser DL; Shore EM; Pignolo RJ; Xu M; Zhang Y; Senitzer D; Forman SJ; Emerson SG
J Bone Joint Surg Am; 2007 Feb; 89(2):347-57. PubMed ID: 17272450
[TBL] [Abstract][Full Text] [Related]
9. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
10. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
Chakkalakal SA; Uchibe K; Convente MR; Zhang D; Economides AN; Kaplan FS; Pacifici M; Iwamoto M; Shore EM
J Bone Miner Res; 2016 Sep; 31(9):1666-75. PubMed ID: 26896819
[TBL] [Abstract][Full Text] [Related]
11. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
van Dinther M; Visser N; de Gorter DJ; Doorn J; Goumans MJ; de Boer J; ten Dijke P
J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436
[TBL] [Abstract][Full Text] [Related]
12. Activation of G
Ebner JK; König GM; Kostenis E; Siegert P; Aktories K; Orth JHC
Bone; 2019 Oct; 127():592-601. PubMed ID: 31376533
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP).
Billings PC; Fiori JL; Bentwood JL; O'Connell MP; Jiao X; Nussbaum B; Caron RJ; Shore EM; Kaplan FS
J Bone Miner Res; 2008 Mar; 23(3):305-13. PubMed ID: 17967130
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.
Nishimori H; Ehata S; Suzuki HI; Katsuno Y; Miyazono K
J Biol Chem; 2012 Jun; 287(24):20037-46. PubMed ID: 22532569
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
[TBL] [Abstract][Full Text] [Related]
16. Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity.
Nordstrand A; Bovinder Ylitalo E; Thysell E; Jernberg E; Crnalic S; Widmark A; Bergh A; Lerner UH; Wikström P
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29670000
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
Dai J; Keller J; Zhang J; Lu Y; Yao Z; Keller ET
Cancer Res; 2005 Sep; 65(18):8274-85. PubMed ID: 16166304
[TBL] [Abstract][Full Text] [Related]
18. Selective Agonists of Nuclear Retinoic Acid Receptor Gamma Inhibit Growth of HCS-2/8 Chondrosarcoma Cells.
Shield WP; Cellini A; Tian H; Wilson K; Dan Y; Abzug JM; Garcia S; Moritani N; Alferiev I; Chorny M; Takigawa M; Ng VY; Iwamoto M; Enomoto-Iwamoto M
J Orthop Res; 2020 May; 38(5):1045-1051. PubMed ID: 31808569
[TBL] [Abstract][Full Text] [Related]
19. Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva.
Lanchoney TF; Olmsted EA; Shore EM; Gannon FA; Rosen V; Zasloff MA; Kaplan FS
Clin Orthop Relat Res; 1998 Jan; (346):38-45. PubMed ID: 9577408
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.
Dai J; Kitagawa Y; Zhang J; Yao Z; Mizokami A; Cheng S; Nör J; McCauley LK; Taichman RS; Keller ET
Cancer Res; 2004 Feb; 64(3):994-9. PubMed ID: 14871830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
